Cabaletta Bio, Inc. (CABA) stock
CABANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30
$1.05+0.03 (+3.43%)
Close on Nov 18, 2026Market cap $178.87MP/E –Yield –
Cabaletta Bio market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Cabaletta Bio's market cap was $300.43M on Apr 30, 2026, against $116.75M a year earlier. Over the last 5 years it ranged from $18.86M to $1.09B, with a median of $261.56M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Apr 30, 2026 | $300.43M | +42.5% |
| 2025 | Dec 31, 2025 | $210.82M | +90.1% |
| 2024 | Dec 31, 2024 | $110.89M | -88.3% |
| 2023 | Dec 29, 2023 | $945.69M | +252.4% |
| 2022 | Dec 30, 2022 | $268.38M | +155.3% |
| 2021 | Dec 31, 2021 | $105.10M | -65.0% |
| 2020 | Dec 31, 2020 | $300.21M | +458.4% |
| 2019 | Dec 31, 2019 | $53.76M | – |
See a number that looks wrong?